医学
免疫疗法
芽孢杆菌(形态)
膀胱癌
卡介苗
癌症免疫疗法
癌症
膀胱
膀胱肿瘤
免疫学
接种疫苗
肿瘤科
泌尿科
内科学
微生物学
生物
作者
Harry W. Herr,Álvaro Morales
标识
DOI:10.1016/j.juro.2007.08.122
摘要
PURPOSE: We review how the bacillus Calmette-Guerin vaccine evolved to become standard therapy for superficial bladder cancer. MATERIALS AND METHODS: We reviewed the historical literature describing the origin of the bacillus Calmette-Guerin vaccine as an anticancer agent and its singular success as the most effective immunotherapy used against a human neoplasm. RESULTS: The association between tuberculosis and cancer, and the demonstration that bacillus Calmette-Guerin invoked immunological reactivity, inhibiting tumor growth in experimental animal models, led to clinical trials showing that intravesical bacillus Calmette-Guerin eradicated and prevented recurrence of superficial bladder tumors. CONCLUSIONS: For the last 3 decades bacillus Calmette-Guerin therapy has remained the most effective local therapy for superficial bladder cancer, an outstanding example of successful translational medicine in urology.
科研通智能强力驱动
Strongly Powered by AbleSci AI